Market Overview - The A-share market experienced an overall decline on October 31, with the Shanghai Composite Index closing at 3954.79 points, down 0.81%, the Shenzhen Component Index at 13378.21 points, down 1.14%, and the ChiNext Index at 3187.53 points, down 2.31%. The North Star 50 Index increased by 1.89% [1] - Total trading volume in the A-share market was 23501.16 billion, a decrease of 1144.6 billion compared to the previous trading day [1] Capital Flow - The main capital outflow from the A-share market was 437.44 billion, with an opening net outflow of 120.47 billion and a closing net outflow of 90.52 billion [2] - The CSI 300 index saw a net outflow of 255.4 billion, while the ChiNext and STAR Market experienced net outflows of 162.56 billion and 57.19 billion, respectively [4] Sector Performance - The pharmaceutical and biotechnology sector led with a net inflow of 155.42 billion, marking a 2.72% increase [6][7] - Other sectors with significant inflows included media (96.02 billion, up 2.98%), computer (92.13 billion, up 1.81%), food and beverage (38.11 billion, up 1.49%), and retail (25.35 billion, up 1.55%) [7] - Conversely, the electronics sector faced the largest outflow at 278.68 billion, down 0.73%, followed by non-ferrous metals at 128.48 billion, down 1.03% [7] Institutional Activity - Oriental Precision Engineering saw the highest net inflow of 12.45 billion [8] - Institutions were active in several stocks, with notable net purchases in Zejing Pharmaceutical (206.78 million) and Shutai Shen (198.10 million) [10][11] Stock Recommendations - Recent institutional focus includes China Life Insurance with a target price of 10.40, indicating a potential upside of 23.22% from the latest closing price [12] - Other stocks with buy ratings include Shanghai Bank (target price 12.02, upside 26.66%) and Yuyue Medical (target price 45.47, upside 26.20%) [12]
【31日资金路线图】医药生物板块净流入155亿元居首 龙虎榜机构抢筹多股
Zheng Quan Shi Bao·2025-10-31 11:53